These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8606781)

  • 1. Doxorubicin in sterically stabilized liposomes.
    Lasic DD
    Nature; 1996 Apr; 380(6574):561-2. PubMed ID: 8606781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal doxorubicin (Doxil).
    Porche DJ
    J Assoc Nurses AIDS Care; 1996; 7(2):55-9. PubMed ID: 8679968
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
    Working PK; Dayan AD
    Hum Exp Toxicol; 1996 Sep; 15(9):751-85. PubMed ID: 8880211
    [No Abstract]   [Full Text] [Related]  

  • 5. Tailoring liposomes for cancer drug delivery: from the bench to the clinic.
    Gabizon A
    Ann Biol Clin (Paris); 1993; 51(9):811-3. PubMed ID: 8166395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy: a means to enhanced drug delivery to tumors.
    Snyder JW; Greco WR; Bellnier DA; Vaughan L; Henderson BW
    Cancer Res; 2003 Dec; 63(23):8126-31. PubMed ID: 14678965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxil receives FDA market clearance.
    AIDS Patient Care STDS; 1996 Apr; 10(2):135. PubMed ID: 11361702
    [No Abstract]   [Full Text] [Related]  

  • 10. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
    Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
    Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD; Dougherty G; Harasym TO; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermia mediated liposomal drug delivery.
    Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
    Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
    Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC
    J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeting therapy of magnetic doxorubicin liposome in nude mice bearing colon cancer].
    Zhou PH; Yao LQ; Qin XY; Shen XZ; Liu YS; Lu WY; Yao M
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2073-6. PubMed ID: 14703420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
    Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
    Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal doxorubicin.
    Tardi PG; Boman NL; Cullis PR
    J Drug Target; 1996; 4(3):129-40. PubMed ID: 8959485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular drug delivery by sulfatide-mediated liposomes to gliomas.
    Shao K; Hou Q; Duan W; Go ML; Wong KP; Li QT
    J Control Release; 2006 Oct; 115(2):150-7. PubMed ID: 16963144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin.
    Veldman RJ; Koning GA; van Hell A; Zerp S; Vink SR; Storm G; Verheij M; van Blitterswijk WJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):704-10. PubMed ID: 16040815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.